Current approaches to combination therapy for essential hypertension: the rationale for combined calcium, channel blockade and beta-blockade

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F13%3A00057977" target="_blank" >RIV/00023001:_____/13:00057977 - isvavai.cz</a>

Výsledek na webu

<a href="http://www.pccj.eu/images/stories/Supplements/PCCJ_Concor_AM_Position_Paper_WEB.pdf" target="_blank" >http://www.pccj.eu/images/stories/Supplements/PCCJ_Concor_AM_Position_Paper_WEB.pdf</a>

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

Current approaches to combination therapy for essential hypertension: the rationale for combined calcium, channel blockade and beta-blockade

Popis výsledku v původním jazyce

Despite the availability of effective therapies, there remains poor awareness, diagnosis and management of hypertension across the globe. Effective treatment requires an understanding of the underlying disease processes involved in hypertension which includes chronic increased sympathetic activity and peripheral resistance rather than focusing simply on blood pressure reduction. The differing pathophysiological response patterns of younger and older hypertensive patients require different treatment pathways and combination antihypertensive therapy is increasingly being used to tackle this heterogeneous condition and to meet international targets for blood pressure reduction. The combination of beta-blockers and calcium channel blockers is recommended in international guidelines for the effective management of hypertension. Combination of these two complementary drug classes targets both heart rate and high sympathetic activity, and abnormal peripheral vascular resistance and arterial s

Název v anglickém jazyce

Current approaches to combination therapy for essential hypertension: the rationale for combined calcium, channel blockade and beta-blockade

Popis výsledku anglicky

Despite the availability of effective therapies, there remains poor awareness, diagnosis and management of hypertension across the globe. Effective treatment requires an understanding of the underlying disease processes involved in hypertension which includes chronic increased sympathetic activity and peripheral resistance rather than focusing simply on blood pressure reduction. The differing pathophysiological response patterns of younger and older hypertensive patients require different treatment pathways and combination antihypertensive therapy is increasingly being used to tackle this heterogeneous condition and to meet international targets for blood pressure reduction. The combination of beta-blockers and calcium channel blockers is recommended in international guidelines for the effective management of hypertension. Combination of these two complementary drug classes targets both heart rate and high sympathetic activity, and abnormal peripheral vascular resistance and arterial s

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FA - Kardiovaskulární nemoci včetně kardiochirurgie

OECD FORD obor

—

Projekt

—

Návaznosti

N - Vyzkumna aktivita podporovana z neverejnych zdroju

Rok uplatnění

2013

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Primary care cardiovascular Journal

ISSN

1756-5138

e-ISSN

—

Svazek periodika

6

Číslo periodika v rámci svazku

suppl. 2

Stát vydavatele periodika

GB - Spojené království Velké Británie a Severního Irska

Počet stran výsledku

9

Strana od-do

"S1"-"S9"

Kód UT WoS článku

—

EID výsledku v databázi Scopus

—